A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers

Marie Helene Schernthaner-Reiter, David Adams, Giampaolo Trivellin, Mary Scott Ramnitz, Margarita Raygada, Gretchen Golas, Fabio R. Faucz, Ola Nilsson, Aikaterini A. Nella, Kavitha Dileepan, Maya Lodish, Paul Lee, Cynthia Tifft, Thomas Markello, William Gahl, Constantine A. Stratakis

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

X-linked nephrogenic diabetes insipidus (NDI, OMIM#304800) is caused by mutations in the arginine vasopressin (AVP, OMIM*192340) receptor type 2 (AVPR2, OMIM*300538) gene. A 20-month-old boy and his 8-year-old brother presented with polyuria, polydipsia, and failure to thrive. Both boys demonstrated partial DDAVP (1-desamino-8-D AVP or desmopressin) responses; thus, NDI diagnosis was delayed. While routine sequencing of AVPR2 showed a potential splice site variant, it was not until exome sequencing confirmed the AVPR2 splice site variant and did not reveal any more likely candidates that the patients’ diagnosis was made and proper treatment was instituted. Both patients were hemizygous for two AVPR2 variants predicted in silico to affect AVPR2 messenger RNA (mRNA) splicing. A minigene assay revealed that the novel AVPR2 c.276A>G mutation creates a novel splice acceptor site leading to 5′ truncation of AVPR2 exon 2 in HEK293 human kidney cells. Both patients have been treated with high-dose DDAVP with a remarkable improvement of their symptoms and accelerated linear growth and weight gain. Conclusion: We present here a unique case of partial X-linked NDI due to an AVPR2 splice site mutation; patients with diabetes insipidus of unknown etiology may harbor splice site mutations that are initially underestimated in their pathogenicity on sequence analysis.(Table presented.)

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalEuropean Journal of Pediatrics
DOIs
StateAccepted/In press - Jan 21 2016
Externally publishedYes

Fingerprint

Nephrogenic Diabetes Insipidus
Genetic Databases
Deamino Arginine Vasopressin
Siblings
Mutation
Exome
RNA Splicing
Polydipsia
Polyuria
Failure to Thrive
Diabetes Insipidus
RNA Splice Sites
Arginine Vasopressin
Delayed Diagnosis
Computer Simulation
Weight Gain
Sequence Analysis
Virulence
Exons
Kidney

Keywords

  • Arginine vasopressin receptor type 2
  • Partial nephrogenic diabetes insipidus
  • Pathogenic splice site mutation
  • X-linked nephrogenic diabetes insipidus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Schernthaner-Reiter, M. H., Adams, D., Trivellin, G., Ramnitz, M. S., Raygada, M., Golas, G., ... Stratakis, C. A. (Accepted/In press). A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers. European Journal of Pediatrics, 1-7. https://doi.org/10.1007/s00431-015-2684-4

A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers. / Schernthaner-Reiter, Marie Helene; Adams, David; Trivellin, Giampaolo; Ramnitz, Mary Scott; Raygada, Margarita; Golas, Gretchen; Faucz, Fabio R.; Nilsson, Ola; Nella, Aikaterini A.; Dileepan, Kavitha; Lodish, Maya; Lee, Paul; Tifft, Cynthia; Markello, Thomas; Gahl, William; Stratakis, Constantine A.

In: European Journal of Pediatrics, 21.01.2016, p. 1-7.

Research output: Contribution to journalArticle

Schernthaner-Reiter, MH, Adams, D, Trivellin, G, Ramnitz, MS, Raygada, M, Golas, G, Faucz, FR, Nilsson, O, Nella, AA, Dileepan, K, Lodish, M, Lee, P, Tifft, C, Markello, T, Gahl, W & Stratakis, CA 2016, 'A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers', European Journal of Pediatrics, pp. 1-7. https://doi.org/10.1007/s00431-015-2684-4
Schernthaner-Reiter, Marie Helene ; Adams, David ; Trivellin, Giampaolo ; Ramnitz, Mary Scott ; Raygada, Margarita ; Golas, Gretchen ; Faucz, Fabio R. ; Nilsson, Ola ; Nella, Aikaterini A. ; Dileepan, Kavitha ; Lodish, Maya ; Lee, Paul ; Tifft, Cynthia ; Markello, Thomas ; Gahl, William ; Stratakis, Constantine A. / A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers. In: European Journal of Pediatrics. 2016 ; pp. 1-7.
@article{746a65b58523494b85774bd5405aaefc,
title = "A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers",
abstract = "X-linked nephrogenic diabetes insipidus (NDI, OMIM#304800) is caused by mutations in the arginine vasopressin (AVP, OMIM*192340) receptor type 2 (AVPR2, OMIM*300538) gene. A 20-month-old boy and his 8-year-old brother presented with polyuria, polydipsia, and failure to thrive. Both boys demonstrated partial DDAVP (1-desamino-8-D AVP or desmopressin) responses; thus, NDI diagnosis was delayed. While routine sequencing of AVPR2 showed a potential splice site variant, it was not until exome sequencing confirmed the AVPR2 splice site variant and did not reveal any more likely candidates that the patients’ diagnosis was made and proper treatment was instituted. Both patients were hemizygous for two AVPR2 variants predicted in silico to affect AVPR2 messenger RNA (mRNA) splicing. A minigene assay revealed that the novel AVPR2 c.276A>G mutation creates a novel splice acceptor site leading to 5′ truncation of AVPR2 exon 2 in HEK293 human kidney cells. Both patients have been treated with high-dose DDAVP with a remarkable improvement of their symptoms and accelerated linear growth and weight gain. Conclusion: We present here a unique case of partial X-linked NDI due to an AVPR2 splice site mutation; patients with diabetes insipidus of unknown etiology may harbor splice site mutations that are initially underestimated in their pathogenicity on sequence analysis.(Table presented.)",
keywords = "Arginine vasopressin receptor type 2, Partial nephrogenic diabetes insipidus, Pathogenic splice site mutation, X-linked nephrogenic diabetes insipidus",
author = "Schernthaner-Reiter, {Marie Helene} and David Adams and Giampaolo Trivellin and Ramnitz, {Mary Scott} and Margarita Raygada and Gretchen Golas and Faucz, {Fabio R.} and Ola Nilsson and Nella, {Aikaterini A.} and Kavitha Dileepan and Maya Lodish and Paul Lee and Cynthia Tifft and Thomas Markello and William Gahl and Stratakis, {Constantine A.}",
year = "2016",
month = "1",
day = "21",
doi = "10.1007/s00431-015-2684-4",
language = "English (US)",
pages = "1--7",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers

AU - Schernthaner-Reiter, Marie Helene

AU - Adams, David

AU - Trivellin, Giampaolo

AU - Ramnitz, Mary Scott

AU - Raygada, Margarita

AU - Golas, Gretchen

AU - Faucz, Fabio R.

AU - Nilsson, Ola

AU - Nella, Aikaterini A.

AU - Dileepan, Kavitha

AU - Lodish, Maya

AU - Lee, Paul

AU - Tifft, Cynthia

AU - Markello, Thomas

AU - Gahl, William

AU - Stratakis, Constantine A.

PY - 2016/1/21

Y1 - 2016/1/21

N2 - X-linked nephrogenic diabetes insipidus (NDI, OMIM#304800) is caused by mutations in the arginine vasopressin (AVP, OMIM*192340) receptor type 2 (AVPR2, OMIM*300538) gene. A 20-month-old boy and his 8-year-old brother presented with polyuria, polydipsia, and failure to thrive. Both boys demonstrated partial DDAVP (1-desamino-8-D AVP or desmopressin) responses; thus, NDI diagnosis was delayed. While routine sequencing of AVPR2 showed a potential splice site variant, it was not until exome sequencing confirmed the AVPR2 splice site variant and did not reveal any more likely candidates that the patients’ diagnosis was made and proper treatment was instituted. Both patients were hemizygous for two AVPR2 variants predicted in silico to affect AVPR2 messenger RNA (mRNA) splicing. A minigene assay revealed that the novel AVPR2 c.276A>G mutation creates a novel splice acceptor site leading to 5′ truncation of AVPR2 exon 2 in HEK293 human kidney cells. Both patients have been treated with high-dose DDAVP with a remarkable improvement of their symptoms and accelerated linear growth and weight gain. Conclusion: We present here a unique case of partial X-linked NDI due to an AVPR2 splice site mutation; patients with diabetes insipidus of unknown etiology may harbor splice site mutations that are initially underestimated in their pathogenicity on sequence analysis.(Table presented.)

AB - X-linked nephrogenic diabetes insipidus (NDI, OMIM#304800) is caused by mutations in the arginine vasopressin (AVP, OMIM*192340) receptor type 2 (AVPR2, OMIM*300538) gene. A 20-month-old boy and his 8-year-old brother presented with polyuria, polydipsia, and failure to thrive. Both boys demonstrated partial DDAVP (1-desamino-8-D AVP or desmopressin) responses; thus, NDI diagnosis was delayed. While routine sequencing of AVPR2 showed a potential splice site variant, it was not until exome sequencing confirmed the AVPR2 splice site variant and did not reveal any more likely candidates that the patients’ diagnosis was made and proper treatment was instituted. Both patients were hemizygous for two AVPR2 variants predicted in silico to affect AVPR2 messenger RNA (mRNA) splicing. A minigene assay revealed that the novel AVPR2 c.276A>G mutation creates a novel splice acceptor site leading to 5′ truncation of AVPR2 exon 2 in HEK293 human kidney cells. Both patients have been treated with high-dose DDAVP with a remarkable improvement of their symptoms and accelerated linear growth and weight gain. Conclusion: We present here a unique case of partial X-linked NDI due to an AVPR2 splice site mutation; patients with diabetes insipidus of unknown etiology may harbor splice site mutations that are initially underestimated in their pathogenicity on sequence analysis.(Table presented.)

KW - Arginine vasopressin receptor type 2

KW - Partial nephrogenic diabetes insipidus

KW - Pathogenic splice site mutation

KW - X-linked nephrogenic diabetes insipidus

UR - http://www.scopus.com/inward/record.url?scp=84955278670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955278670&partnerID=8YFLogxK

U2 - 10.1007/s00431-015-2684-4

DO - 10.1007/s00431-015-2684-4

M3 - Article

SP - 1

EP - 7

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

ER -